Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Kusum Tom"'
Autor:
Kalathil K Sureshkumar, Carlos A Vivas, Ngoc Thai, Kusum Tom, George Parris, Sabiha M Hussain, Tina Y. Ko, Akhtar Khan, Katherine M. Jasnosz, Richard J. Marcus
Publikováno v:
Clinical Nephrology. 77:246-253
Antibody-mediated rejection (AMR) following renal transplantation is less responsive to conventional anti-rejection therapies. Plasmapheresis (PP), intravenous immunoglobulin (IVIg), rabbit antithymocyte globulin (rATG) and rituximab deplete immature
Autor:
Margaret V. Ragni, M. E. de Vera, Obaid Shakil, Igor Dvorchik, Amadeo Marcos, Ashokkumar Jain, John J. Fung, Ngoc Thai, Kusum Tom, Anthony J. Demetris, Bijan Eghtesad
Publikováno v:
American Journal of Transplantation. 6:2983-2993
Although liver transplantation (LTx) in HIV-positive patients receiving highly active antiretroviral therapy (HAART) has been successful, some have reported poorer outcomes in patients coinfected with hepatitis C virus (HCV). Here we discuss the impa
Autor:
Adrian W. Ong, Kusum Tom
Publikováno v:
Complications in Surgery and Trauma ISBN: 9780429169939
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f600e24c63aa52ccdb252f6ca8dbe3d8
https://doi.org/10.1201/b16377-17
https://doi.org/10.1201/b16377-17
Autor:
Jacqueline Poydence, Anil Singh, Robert W Biederman, Ronald B Williams, June Yamrozik, Moneal Shah, Swami Nathan, Asghar Fakhri, Michael K. Dishart, Mark Doyle, Jose Oliva, Ngoc Thai, Saundra B Grant, Kusum Tom, Sahadev T Reddy
Publikováno v:
Transplantation. 96(9)
Background Preoperative cardiovascular risk stratification in orthotopic liver transplantation candidates has proven challenging due to limitations of current noninvasive modalities. Additionally, the preoperative workup is logistically cumbersome an
Alemtuzumab pretreatment and tacrolimus monotherapy in living-donor liver and kidney transplantation
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 7(2)
We previously described the use of alemtuzumab as a pretreatment agent in 207 living-donor renal transplants, a trial that represented the largest series to date of live-donor renal and liver transplant recipients undergoing alemtuzumab pretreatment,
Autor:
J. Britz, Ron Shapiro, Carol Bentlejewski, Henkie P. Tan, Amadeo Marcos, Adriana Zeevi, Richard Kowalski, Amit Basu, Deanna Blisard, Janice Glidewell, Cindy Smetanka, John J. Fung, Ngoc Thai, Kusum Tom
Publikováno v:
Transplantation. 82(12)
BACKGROUND Alemtuzumab induction and tacrolimus-based immunosuppression has been effective in pancreas transplantation. Despite the encouraging results of this minimalistic approach to immunosuppression, infection still remains a significant cause of
Autor:
Deanna Blisard, John J. Fung, Henkie P. Tan, Amit Basu, Akhtar Khan, Ngoc Thai, Ron Shapiro, Thomas E. Starzl, Amadeo Marcos, Kusum Tom
BACKGROUND. Alemtuzumab (Campath-1H) induction with tacrolimus monotherapy has been shown to provide effective immunosuppression for kidney, liver, lung, and small bowel transplantation. This drug combination was evaluated in pancreas transplant reci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb44dc88e3199aa04ae01117ac1be9c
https://europepmc.org/articles/PMC2952504/
https://europepmc.org/articles/PMC2952504/
Autor:
Thomas A. Shaw-Stiffel, Dympna Kelly, John J. Fung, Linda Boig, Paulo Fontes, Raymond M. Planinsic, Kusum Tom, Amadeo Marcos, Bijan Eghtesad, Paula M. Novelli, Anthony J. Demetris, Heinke P. Tan, J. Wallis Marsh
Publikováno v:
The American journal of surgical pathology. 30(8)
In an attempt to more completely define the histopathologic features of the portal vein hyperperfusion or small-for-size syndrome (PHP/SFSS), we strictly identified 5 PHP/SFSS cases among 39 (5/39; 13%) adult living donor liver transplants (ALDLT) co
Autor:
Mohmmadreza, Rohaninejad, Bijan, Eghtesad, Kusum, Tom, Zakiyah, Kadry, Mojgan, Morshedi, Gruttadauria, Salvatore Giovanni, Wallis, Marsh, John, Fung, Bruno, Gridelli, Amadeo, Marcos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::edc24e2a13b7f2f5bc9b2a6fb13a25a9
http://hdl.handle.net/20.500.11769/102576
http://hdl.handle.net/20.500.11769/102576
Autor:
Alexander V. Kirichenko, William Ross Green, James G. Christensen, Ellen Day, Akhtar Khan, Erik Lappinen, Ngoc Thai, Kusum Tom
Publikováno v:
Journal of Clinical Oncology. 30:347-347
347 Background: Evaluate the feasibility, safety, and efficacy of SBRT in combination with surgery for primary and metastatic liver tumors. Methods: 12 patients completed hepatectomy and SBRT for either hepatocellular carcinoma (HCC) (3) or metastase